CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PharmaBlock Sciences Nanjing Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PharmaBlock Sciences Nanjing Inc
No. 10 Xuefu Road
Hi-tech Industrial Development Zone
Phone: +86 2586918230p:+86 2586918230 NANJING, JNG  210032  China Ticker: 300725300725
Business Summary
PharmaBlock Sciences Nanjing Inc is a company mainly engaged in design, synthesis and sales of pharmaceutical molecular building blocks. The Company's primary products include aromatic heterocyclic drug molecular building blocks, common saturated alicyclic drug molecular building blocks, four-membered ring drug molecular building blocks and special saturated ring drug molecular building blocks. The Company is also involved in development, production and sales of pharmaceutical intermediates, and provides technical services related to the development and process production of pharmaceutical molecular building blocks.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2899 Chemicals and chemical preparations, not elsewhere classified
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager MinminYang 51 4/21/2023 12/1/2014
Chief Financial Officer YifeiWu 43 6/1/2021 6/1/2021
Vice President, Deputy General Manager JingLi 49 11/30/2018 11/30/2018
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
PHARMABLOCK (USA), INC 777 SCHWAB RD HATFIELD PA

Business Names
Business Name
300725
PharmaBlock (USA), Inc.

General Information
Number of Employees: 2,429 (As of 6/30/2023)
Outstanding Shares: 199,664,658 (As of 3/31/2024)
Shareholders: 22,316
Stock Exchange: SHE
Fax Number: +86 2586918262


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024